Hemophagocytic syndrome in patients with adult-onset Still’s disease: Diagnostic problems


Cite item

Full Text

Abstract

Hemophagocytic syndrome (HPS) is a rare life-threatening condition caused by massive cytokine release from activated macrophages and lymphocytes. The paper depicts the development of HPS in different infections, malignancies, and autoimmune diseases. It describes a clinical case of hemophagocytic syndrome in a 63-year-old female patient with adult-onset Still’s disease and high fever accompanied by neutrophil leukocytosis and a drastic left leukocyte count shift, high procalcitonin levels, hepatosplenomegaly, edematous syndrome, and progressive multiple organ dysfunction with the development of disseminated intravascular coagulation and adult respiratory distress syndrome. The diagnosis of HPS was established according to the diagnostic criteria and verified by autopsy: phagocytes in liver and lung tissues.

References

  1. Efthimiou P, Paik PK, Bielory L. Diagnosis and management of adult oneset Still`s disease. Ann Rheum Dis. 2006;65:564-572.
  2. Kounami S, Minami K, Yoshiyama M, Izumi G, Aoyagi N, Yoshikawa N. Fatal hemophagocytic lymphohistiocytosis presenting as Reye′s syndrome: Report of two cases. Open J Pediatr. 2012;2:161-164.
  3. Filipovich A, McClain K, Crom A. Histiocytic disorders: recent insights into pathophysiology and practical guidelines. Biol Blood MarrowTransplant. 2010;16(1 suppl):82-89.
  4. Ramos-Casals M, Brito-Zerуn P, Lуpez-Guillermo A, MA Khamashta, Bosch X. Adult haemophagocytic syndrome. Lancet. 2014;383:1503-1516.
  5. Kumakura S. Hemophagocytic syndrome. Intern Med. 2005;44(4):278-280.
  6. Janka GE. Hemophagocytic lymphohistiocytosis. Hematology. 2005;10 Supplement 1:104-107.
  7. Henter JI, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol. 1991;18:29-33.
  8. Henter JI, Horne A, Aricó M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124-131.
  9. Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL. How I treat hemophagocytic lymphohisiocytosis. Blood. 2011;118(15):4041-4052.
  10. Ravelli A, Magni-Manzoni S, Pistorio A, Besana C, Foti T, Ruperto N, Viola S, Martini A. Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Pediatr. 2005;146(5):598-604.
  11. Davi S, Consolara A, Guseinova D, Pistorio A, Ruperto N, Martini A, Cron RQ, Ravelli A; MAS Study Group. An International Consensus Survey of Diagnostic Criteria for Macrophage activation syndrome in systemic juvenile idiopathic arthritis. J Rheumatol. 2011;38;764-768.
  12. Scire CA, Cavagna L, Perotti C, Bruschi E, Caporali R, Montecucco C. Diagnostic value of procalcitonin measurement in febrile patient with systemic autoimmune disease. Clin Exp Rheumatol. 2006;24:123-128.
  13. Rosario С, Zandman-Goddard G, Meyron-Holtz EG, D’Cruz DP, Shoenfeld Y. The Hyperferritinemic Syndrome: macrophage activation syndrome, Still’s disease, septic shock and catastrophic antiphospholipid syndrome. BMC Med. 2013;11:185.
  14. Larroche C, Ziol M, Zidi S. Atteinte hepatique au cours du syndrome d`activation macrophagique. Gastroenterol Clin Biol. 2007;31:959-966.
  15. De Kerguenec C, Hillaire S, Molinie V, Gardin C, Degott C, Erlinger S, Valla D. Hepatic manifestetions of hemophagocytic syndrome: a stady of 30 cases. Am J Gasroenterol. 2001;96:852-857.
  16. Arlet J-B, Thi Huong DLe, Marincho A, Amoura Z, Wechsler B, Papo T, Piette JC. Reactive haemophagocytic syndrome in adult-onset Still`s disease: a report of six patients and a review of the literature. Ann RheumDis. 2006;65:1956-1601.
  17. Kaito K, Kabayashi M, Katayama T, Otsubo H, Ogasawara Y, Sekita T, Saeki A, Sakamoto M, Nishiwaki K, Masuoka H, Shimada T, Yoshida M, Hosoya T. Prognostic factors of hemophgocytic syndrome in adults: analysis of 34 cases. Eur J Haematol. 1997;59:247-253.
  18. Wakabayashi K, Inokuma S, Matsubara E, Onishi K, Asashima H, Nakachi S, Hagiwara K. Serum β2-microglobulin level is a useful indicator of disease activity and hemophagocytic syndrome complication in systemic lupus erythematosus and adult-onset Still`s disease. Clin Rheumathol. 2013;32:999-1005.
  19. Родионовская С.Р., Никишина И.П. Синдром активации макрофагов у больных системным ювенильным артритом. Научно-практическая ревматология. 2014;52(2):202-208.
  20. Souabni L, Dridi L, Ben Abdelghani K, Kassab S, Chekili S, Laater A, Zakraoui L. Possible macrophage activation syndrome following initiation of adalimumab in a patient with adult-onset Still’s disease. Pan Afr Med J. 2014;17:94.
  21. Kamiya K, Kurasawa K, Arai S, Maezawa R, Hanaoka R, Kumano K, Fukuda T. Rituximab was effective on refractory thrombotic thrombocytopenic purpura but induced a flare of hemophagocytic syndrome in a patient with systemic lupus erythematosus. Mod Rheumatol. 2010;20:81-85.
  22. Sundhu C, Chesney A, Pihotis FH, Buckstein R, Koren S. Macrophage activation syndrome after etenercept treatment. J Rheumatol. 2007;34: 241-242.
  23. Larroche C. Hemophagpcytic lymphohistiocytisis in adults: diagnosis and treatment. Joint Bone Spine. 2012;79:356-361.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2015 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies